Screen Shot 2019-08-01 at 4.13.38 pm.png

STOCKHEAD | Dr Boreham’s Crucible: Has Imugene now got the assets it needs to fast-track an acquisition?

July 29, 2019


Screen Shot 2019-07-25 at 11.17.58 am.png

Next Biotech | IMU’s Latest Cancer Treatment Acquisition Could Have Big Pharma Knocking

July 25, 2019


Screen Shot 2019-07-17 at 3.47.40 pm.png

The Australian BUSINESS REVIEW: Imugene buys cancer-fighting virus

July 17, 2019


Screen Shot 2019-04-24 at 1.52.00 pm.png

MicroCap Review Magazine: Profiled Company - Imugene Limited, An Emerging Leader in Cancer Immuno-Oncology.

April 2019


Screen Shot 2019-03-26 at 9.49.48 pm.png

OHIO STATE Oncology Update: Novel Anticancer Vaccine Shows Promise in Phase I Study - featuring our Scientific Advisory Board Member Professor Pravin Kaumaya, PhD.

March 26, 2019


Your Money - Chairman Paul Hopper interviewed on Trading Day.

January 7, 2019


Screen Shot 2018-12-17 at 11.52.38 pm.png

Fierce Biotech - Imugene ‘encouraged’ by data for HER2 vaccine in gastric cancer

December 17, 2018


Screen Shot 2018-12-17 at 11.49.08 pm.png

SMALL CAPS - Imugene’s Phase 1b HER-Vaxx cancer trial meets endpoints, reports positive results

December 17, 2018


Screen Shot 2018-12-17 at 11.44.55 pm.png

STOCKHEAD - Imugene’s gastric cancer drug clears first safety hurdles

December 17, 2018


Screen Shot 2018-11-21 at 11.04.06 am.png

next BIOTECH - Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent

November 13, 2018


Screen Shot 2018-09-06 at 12.50.42 pm.png

The Australian Financial Review - Why it’ll pay to be more open to biotech investment opportunities

July 31, 2018


Screen Shot 2018-12-11 at 8.56.23 am.png

The Sydney Morning Herald - Cancer-fighter Imugene looking to spark interest of big pharma

July 2, 2018


Screen Shot 2018-09-06 at 12.54.41 pm.png

The Australian Financial Review - Imugene to raise $20m, fund trials at Ohio State University, Mayo Clinic

June 6, 2018


Screen Shot 2018-09-17 at 2.05.01 pm.png

The Australian - Biotech entrepreneur Hopper brings companies to life

May 14, 2018


Screen Shot 2018-09-06 at 11.42.39 am.png

The Australian Financial Review -  New thinking answers call of progress

April 7, 2017


Screen Shot 2018-09-06 at 11.49.34 am.png

The Australian Business Review - Imugene CEO Leslie Chong: meet the unicorn leading the cancer fight

March 5, 2017


Screen Shot 2018-09-06 at 11.53.54 am.png

The Sydney Morning Herald - Breakthrough for local biotech as an influential backer emerges

March 3, 2017


Screen Shot 2018-09-06 at 12.18.52 pm.png

Life Scientist - Imugene candidate increases cancer-fighting antibodies

April 20, 2017


Screen Shot 2018-09-06 at 12.20.42 pm.png

Bionity.com - HER-Vaxx Re-formation shows dramatic ten-fold increase in Antibodies and early onset of response

April 22, 2017


Screen Shot 2018-09-06 at 12.28.37 pm.png

Global Health and Travel - Cancer Vaccines, The New Wave of Immune System-Based Oncology

April 2015


Screen Shot 2018-09-06 at 12.39.02 pm.png

Proactive Investors -  Imugene meets heavy demand in capital raising for HER-Vaxx

December 9, 2014


Screen Shot 2018-09-06 at 12.41.57 pm.png

Proactive Investors - HER-Vaxx peptides demonstrate high level of activity

December 1, 2014 


Screen Shot 2018-09-06 at 12.44.54 pm.png

Life Scientist - Imugene Engages Mymetics to Manufacture HER-Vaxx Cancer Immunotherapy

July 16, 2014


Screen Shot 2018-09-06 at 1.00.57 pm.png

Life Scientist - Imugene picks peptide manufacturer for HER-Vaxx

May 28, 2014


Screen Shot 2018-09-06 at 1.03.53 pm.png

Proactive Investors - Imugene to be granted patent for cancer vaccine in Israel

March 24, 2014


Screen Shot 2018-09-06 at 1.09.01 pm.png

Life Scientist - Imugene kicks off IND process for HER-Vaxx

March 18, 2014